Gastrointestinal Products Market by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), Gastrointestinal cancer), End-User (Hospitals, ASC) - Forecast to 2029
The global Gastroenterology/Gastrointestinal Products Market is projected to reach USD 19.7 billion by 2029 from USD 14.7 billion in 2024, at a CAGR of 6.1% from 2024 to 2029. The market for gastroenterology and gastrointestinal products is driven by several factors, such as the growing incidence of GI disorders, improvements in technology, aging populations, rising healthcare costs, increased awareness and screening initiatives, rising R&D spending, the need for personalized medicine, and economic expansion in emerging markets. The GI product industry is dynamic and ever-evolving due to the combined influence of these drivers.
“The endoscopy segment from the devices segment accounted for the largest share during the forecast period.”
The Gastroenterology/Gastrointestinal product market is divided into Endoscopy, Ablations systems, Motility testing, Stenting devices, Ph monitoring, and other devices. The endoscopy segment accounted for the largest share during the forecast period. Endoscopic techniques enable the removal of polyps, tissue biopsies, stent implantation, and tumor ablation, among other therapeutic and diagnostic treatments. These developments support endoscopy's increasing use for a range of gastrointestinal disorders.
“The GERD segment in the diseases segment accounted for the largest share during the forecast period..”
The increasing prevalence of GERD, driven by lifestyle factors, obesity, aging populations, and enhanced diagnostic and treatment options, is significantly boosting the share of the gastroenterology market. As awareness grows and technological advancements continue, the demand for gastroenterological products and services is expected to rise, further driving market growth. As the global population ages, the incidence of GERD increases. Older adults are more susceptible to GERD due to changes in esophageal motility and the function of the lower esophageal sphincter.
“APAC is estimated to register the highest CAGR during the forecast period.”
The Gastroenterology/Gastrointestinal Products Market is divided into Five regions- North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The Asia Pacific is witnessed to have the highest CAGR during the forecast period.. Many APAC countries, including Japan, South Korea, and China, are witnessing demographic shifts as their populations age. Older persons have a higher prevalence of diseases like GERD and complex healthcare needs.
Breakdown of supply-side primary interviews, by company type, designation, and region:
This report studies the Gastroenterology/Gastrointestinal Products Market based on devices, diseases, end-users and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets concerning their growth trends, prospects, and contributions to the total Gastroenterology/Gastrointestinal Products Market. The report forecasts the revenue of the market segments to five major regions.
Reasons to Buy the Report
This report also includes.
“The endoscopy segment from the devices segment accounted for the largest share during the forecast period.”
The Gastroenterology/Gastrointestinal product market is divided into Endoscopy, Ablations systems, Motility testing, Stenting devices, Ph monitoring, and other devices. The endoscopy segment accounted for the largest share during the forecast period. Endoscopic techniques enable the removal of polyps, tissue biopsies, stent implantation, and tumor ablation, among other therapeutic and diagnostic treatments. These developments support endoscopy's increasing use for a range of gastrointestinal disorders.
“The GERD segment in the diseases segment accounted for the largest share during the forecast period..”
The increasing prevalence of GERD, driven by lifestyle factors, obesity, aging populations, and enhanced diagnostic and treatment options, is significantly boosting the share of the gastroenterology market. As awareness grows and technological advancements continue, the demand for gastroenterological products and services is expected to rise, further driving market growth. As the global population ages, the incidence of GERD increases. Older adults are more susceptible to GERD due to changes in esophageal motility and the function of the lower esophageal sphincter.
“APAC is estimated to register the highest CAGR during the forecast period.”
The Gastroenterology/Gastrointestinal Products Market is divided into Five regions- North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The Asia Pacific is witnessed to have the highest CAGR during the forecast period.. Many APAC countries, including Japan, South Korea, and China, are witnessing demographic shifts as their populations age. Older persons have a higher prevalence of diseases like GERD and complex healthcare needs.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
- By Designation: C-level (30%), Director-level (20%), and Others (50%)
- By Region: North America (35%), Europe (24%), Asia Pacific (25%), RoW(16%)
- BOSTON SCIENTIFIC (U.S)
- MEDTRONIC (U.S)
- OLYMPUS CORPORATION (JAPAN)
- STRYKER (U.S.)
- GLOBUS MEDICAL (U.S.)
- COOK MEDICAL (US)
- ETHICON (SUBSIDIARY OF J&J)
- FUJIFILM (JAPAN)
- CONMED CORPORATION (US)
- KARL STORZ (GERMANY)
This report studies the Gastroenterology/Gastrointestinal Products Market based on devices, diseases, end-users and region. The report also analyses factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets concerning their growth trends, prospects, and contributions to the total Gastroenterology/Gastrointestinal Products Market. The report forecasts the revenue of the market segments to five major regions.
Reasons to Buy the Report
This report also includes.
- Analysis of key drivers (increasing GI diseases, technological advancements) , restraints (Cost of the system), challenges(regulatory policies), and opportunities (Increase in the minimally invasive procedures) contributing to the growth of the Gastroenterology/Gastrointestinal Products Market.
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, in the Gastroenterology/Gastrointestinal Products Market.
- Market Development: Comprehensive information on the lucrative emerging markets by devices, diseases, end-users and region.
- Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the Gastroenterology/Gastrointestinal Products Market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Gastroenterology/Gastrointestinal Products Market..
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET OVERVIEW
4.2 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE AND REGION (2023)
4.3 GEOGRAPHIC SNAPSHOT OF GASTROENTEROLOGY/GASTROINTESTINAL
PRODUCTS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of GI disorders
5.2.1.2 Technological advancements in gastroenterology products
5.2.1.3 Growing aging population
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory policies for GI products
5.2.2.2 Increasing healthcare costs
5.2.2.3 Unfavorable healthcare reforms in US
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing preference for minimally invasive surgery
5.2.4 CHALLENGES
5.2.4.1 Changing regulatory landscape
5.2.4.2 Shortage of trained physicians and endoscopists
5.3 INDUSTRY TRENDS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Capsule endoscopy
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Laboratory testing
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Robotic surgery systems
5.5 VALUE CHAIN ANALYSIS
5.6 PORTER’S FIVE FORCE ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY ANALYSIS
5.7.1.1 North America
5.7.1.1.1 US
5.7.1.1.2 Canada
5.7.1.2 Europe
5.7.1.3 Asia Pacific
5.7.1.3.1 Japan
5.7.1.3.2 China
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 HS CODES: GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS
5.9.2 IMPORT DATA
5.9.3 EXPORT DATA
5.10 PRICING ANALYSIS
5.11 REIMBURSEMENT ANALYSIS
5.12 KEY CONFERENCES & EVENTS, 2024–2025
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 UNMET NEEDS ANALYSIS
5.15 END-USER EXPECTATIONS
5.16 ECOSYSTEM ANALYSIS
5.17 CASE STUDY ANALYSIS
5.18 SUPPLY CHAIN ANALYSIS
5.19 INVESTMENT & FUNDING SCENARIO
5.20 IMPACT OF GEN AI/AI ON GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
6 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE
6.1 INTRODUCTION
6.2 ENDOSCOPY DEVICES
6.2.1 FLEXIBLE ENDOSCOPES
6.2.1.1 Advantages such as flexibility and ease of use to drive demand for flexible endoscopes
6.2.2 RIGID ENDOSCOPES
6.2.2.1 Ability of rigid endoscopes to provide vertical-axis images of internal organs to support market growth
6.2.3 CAPSULE ENDOSCOPES
6.2.3.1 Non-invasive nature of capsule endoscopes to drive adoption
6.2.4 OTHER ENDOSCOPY DEVICES
6.3 ABLATION DEVICES
6.3.1 RADIOFREQUENCY ABLATION DEVICES
6.3.1.1 Low cost of radiofrequency ablation to contribute to market growth
6.3.2 MICROWAVE ABLATION DEVICES
6.3.2.1 Advantages over RF ablation to ensure sustained demand for microwave ablation devices
6.3.3 CRYOABLATION DEVICES
6.3.3.1 Increasing cancer incidence to drive market for cryoablation devices
6.3.4 LASER ABLATION DEVICES
6.3.4.1 High efficacy and safety to drive adoption of laser/light ablation devices
6.3.5 OTHER ABLATION DEVICES
6.4 MOTILITY TESTING DEVICES
6.4.1 ESOPHAGEAL MANOMETRY DEVICES
6.4.1.1 Rising incidence of esophageal motility disorders to boost market growth
6.4.2 4-HOUR PH IMPEDANCE TESTING DEVICES
6.4.2.1 Ability to provide data useful for tailoring individualized treatment plans to favor market growth
6.4.3 ANORECTAL MANOMETRY DEVICES
6.4.3.1 Growing popularity of anorectal manometry devices for diagnosis of gastrointestinal problems to support market growth
6.4.4 OTHER MOTILITY TESTING DEVICES
6.5 BIOPSY DEVICES
6.5.1 NEEDLE BIOPSY DEVICES
6.5.1.1 Increasing screening of gastrointestinal diseases to aid growth
6.5.2 OTHER BIOPSY DEVICES
6.6 STENTING DEVICES
6.6.1 BILIARY STENTS
6.6.1.1 Increasing prevalence of bile duct cancer and chronic liver disease to drive growth
6.6.2 COLONIC STENTS
6.6.2.1 Rising demand for colonic stents due to high incidence of colorectal cancer to drive segmental growth
6.6.3 DUODENAL STENTS
6.6.3.1 Increasing prevalence of intestinal malignancy to boost adoption of duodenal stents
6.6.4 PANCREATIC STENTS
6.6.4.1 Rising number of ERCP and PTC procedures to drive market growth
6.6.5 ESOPHAGEAL STENTS
6.6.5.1 Increasing incidence of esophageal cancer to propel market growth
6.7 PH MONITORING DEVICES
6.7.1 ESOPHAGEAL PH MONITORING CATHETERS
6.7.1.1 Growing sedentary lifestyles to drive demand
6.7.2 WIRELESS PH MONITORING CAPSULES
6.7.2.1 Reduced risk of open surgeries to boost market
6.7.3 AMBULATORY PH MONITORING SYSTEMS
6.7.3.1 Convenience and accuracy of ambulatory pH monitoring to drive market
6.8 OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES
6.8.1 GASTRIC BALLOONS
6.8.1.1 Minimally invasive nature of gastric balloons to boost adoption
6.8.2 GASTROINTESTINAL TUBES
6.8.2.1 Rising incidence of diseases to drive need for gastrointestinal tubes
6.8.3 HEMORRHOID TREATMENT DEVICES
6.8.3.1 Rising cases of hemorrhoids to support market growth
7 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE
7.1 INTRODUCTION
7.2 GASTROINTESTINAL CANCERS
7.2.1 CHANGING DIETS AND GROWING PREVALENCE OF OBESITY TO BOOST MARKET GROWTH
7.3 GASTROESOPHAGEAL REFLUX DISEASE
7.3.1 GROWING INCIDENCE OF GERD TO DRIVE MARKET GROWTH
7.4 IRRITABLE BOWEL SYNDROME (IBS)
7.4.1 GROWING IBS DISEASE BURDEN TO DRIVE DEMAND FOR GASTROINTESTINAL PRODUCTS
7.5 INFLAMMATORY BOWEL DISEASE (IBD)
7.5.1 GROWING USE OF CAPSULE ENDOSCOPES IN TREATING IBD TO FAVOR MARKET GROWTH
7.6 OTHER DISEASES
8 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.2.1 HIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL PROCEDURES IN HOSPITALS
8.3 AMBULATORY SURGICAL CENTERS & INDEPENDENT SURGICAL CENTERS
8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE MARKET GROWTH
8.4 CLINICS
8.4.1 GROWING NEED FOR CLINICAL SCREENING TO DIAGNOSE GASTROINTESTINAL DISEASES TO BOOST MARKET
8.5 OTHER END USERS
9 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 US to dominate North American market during forecast period
9.2.3 CANADA
9.2.3.1 Increased availability of funding and presence of research institutes to propel market
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Favorable reimbursement scenario and increased geriatric population to aid market growth
9.3.3 UK
9.3.3.1 Rising investments by hospitals in new and advanced gastroenterology/gastrointestinal products to augment market growth
9.3.4 FRANCE
9.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth
9.3.5 ITALY
9.3.5.1 High per capita income and improved healthcare system to drive market
9.3.6 SPAIN
9.3.6.1 Growing prevalence of cardiovascular diseases to boost market growth
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 JAPAN
9.4.2.1 Favorable medical device reimbursement policies and public health insurance schemes to aid market growth
9.4.3 CHINA
9.4.3.1 Increasing geriatric population and increase in domestic manufacturers for gastrointestinal products to support growth
9.4.4 INDIA
9.4.4.1 Increasing incidence of diseases like diabetes to enhance market growth
9.4.5 AUSTRALIA
9.4.5.1 High incidence of cancer to propel market growth
9.4.6 SOUTH KOREA
9.4.6.1 Rapidly aging population and high incidence of gastrointestinal diseases to aid market growth
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Increase in private healthcare investments and rise in medical tourism to aid market growth
9.5.3 MEXICO
9.5.3.1 Increased government investment in healthcare infrastructure and technological advancements to aid market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2 GCC COUNTRIES
9.6.2.1 Increasing investment in healthcare infrastructure and growing medical tourism to propel market growth
9.6.3 REST OF MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
10.3 REVENUE ANALYSIS, 2021–2023
10.4 MARKET SHARE ANALYSIS, 2023
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
10.5.5.1 Company footprint
10.5.5.2 Disease footprint
10.5.5.3 End-user footprint
10.5.5.4 Region footprint
10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
10.7.3 EXPANSIONS
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPANY VALUATION & FINANCIAL METRICS
10.9.1 FINANCIAL METRICS
10.9.2 COMPANY VALUATION
11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 OLYMPUS CORPORATION
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Product launches & approvals
11.1.1.3.2 Deals
11.1.1.3.3 Expansions
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 BOSTON SCIENTIFIC CORPORATION
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product launches & approvals
11.1.2.3.2 Deals
11.1.2.4 MnM view
11.1.2.4.1 Right to win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 MEDTRONIC PLC
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Product approvals
11.1.3.3.2 Deals
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 STRYKER CORPORATION
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.4.3.1 Product approvals
11.1.4.3.2 Deals
11.1.4.3.3 Expansions
11.1.4.4 MnM view
11.1.4.4.1 Right to win
11.1.4.4.2 Strategic choices
11.1.4.4.3 Weaknesses & competitive threats
11.1.5 COOK MEDICAL
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.3.1 Product launches & approvals
11.1.5.3.2 Deals
11.1.5.4 MnM view
11.1.5.4.1 Right to win
11.1.5.4.2 Strategic choices
11.1.5.4.3 Weaknesses & competitive threats
11.1.6 FUJIFILM CORPORATION
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Product launches & approvals
11.1.6.3.2 Other developments
11.1.7 CONMED CORPORATION
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.8 ETHICON (A JOHNSON & JOHNSON SUBSIDIARY)
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.8.3 Recent developments
11.1.8.3.1 Product launches & approvals
11.1.9 MERIT MEDICAL SYSTEMS
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.9.3 Recent developments
11.1.9.3.1 Product launches
11.1.10 STERIS PLC
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.11 KARL STORZ SE & CO. KG
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.11.3 Recent developments
11.1.11.3.1 Deals
11.2 OTHER PLAYERS
11.2.1 SHAILI ENDOSCOPY
11.2.2 TAEWOONG MEDICAL CO., LTD.
11.2.3 HOBBS MEDICAL, INC.
11.2.4 PENTAX MEDICAL
11.2.5 ERBE ELEKTROMEDIZIN
11.2.6 AMBU A/S
11.2.7 CAPSOVISION, INC.
11.2.8 INTROMEDIC, INC.
11.2.9 VIMEX ENDOSCOPY
11.2.10 TRIVITRON HEALTHCARE
11.2.11 MEDI-GLOBE CORPORATION
11.2.12 SONOSCAPE MEDICAL CORP.
11.2.13 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
11.2.14 MEDSPIRA
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 GLOBAL HEALTHCARE EXPENDITURES, BY REGION, 2022–2023
TABLE 3 ASIA PACIFIC: HEALTHCARE EXPENDITURE, BY COUNTRY, 2022–2023
TABLE 4 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
PORTER’S FIVE FORCES ANALYSIS
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 10 HS CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS
TABLE 11 IMPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 12 EXPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 13 AVERAGE SELLING PRICE OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS, BY KEY PLAYER, 2023 (USD)
TABLE 14 AVERAGE SELLING PRICE OF GASTROINTESTINAL PRODUCTS, BY REGION,
2021–2023
TABLE 15 REIMBURSEMENT CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL PROCEDURES
TABLE 16 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
KEY CONFERENCES & EVENTS, 2024–2025
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
TABLE 18 KEY BUYING CRITERIA FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
TABLE 19 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: UNMET NEEDS
TABLE 20 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: END-USER EXPECTATIONS
TABLE 21 CASE STUDY 1: AI-ENHANCED CAPSULE ENDOSCOPY FOR SMALL BOWEL
DISEASE DETECTION
TABLE 22 CASE STUDY 2: RADIOFREQUENCY ABLATION FOR BARRETT'S ESOPHAGUS
TABLE 23 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: AI INTEGRATION
TABLE 24 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 25 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 26 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (THOUSAND UNITS)
TABLE 27 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 28 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CAPSULE ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ENDOSCOPY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 33 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, VOLUME DATA 2022–2029 (THOUSAND UNITS)
TABLE 34 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MICROWAVE ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CRYOABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR LASER ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 41 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL MANOMETRY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR 4-HOUR PH IMPEDANCE TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ANORECTAL MANOMETRY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER MOTILITY TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 47 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR NEEDLE BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR OTHER BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 51 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (THOUSAND UNITS)
TABLE 52 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 BILIARY STENTS OFFERED BY PROMINENT PLAYERS
TABLE 54 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BILIARY STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 COLONIC STENTS OFFERED BY PROMINENT PLAYERS
TABLE 56 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR COLONIC STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 DUODENAL STENTS OFFERED BY PROMINENT PLAYERS
TABLE 58 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR DUODENAL STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 PANCREATIC STENTS OFFERED BY PROMINENT PLAYERS
TABLE 60 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PANCREATIC STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 ESOPHAGEAL STENTS OFFERED BY PROMINENT PLAYERS
TABLE 62 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 64 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL PH MONITORING CATHETERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR WIRELESS PH MONITORING CAPSULES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY PH MONITORING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 69 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 70 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTRIC BALLOONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL TUBES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 72 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HEMORRHOID TREATMENT DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 73 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 74 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL CANCERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD), BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 76 TYPES OF IBS WITH SEVERITY INDEX
TABLE 77 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR IRRITABLE BOWEL SYNDROME (IBS), BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR INFLAMMATORY BOWEL DISEASE (IBD), BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 80 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 81 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 82 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY SURGICAL CENTERS & INDEPENDENT DIAGNOSTIC CENTERS, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 83 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 86 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 87 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 89 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 93 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
TABLE 96 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 97 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2024
TABLE 98 LIST OF DEVICES THAT RECEIVED FDA APPROVALS BETWEEN 2020 AND 2023
TABLE 99 US: MACROECONOMIC INDICATORS
TABLE 100 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 101 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 102 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 103 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 104 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 105 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 106 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 107 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 108 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 109 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 110 CANADA: MACROECONOMIC INDICATORS
TABLE 111 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 112 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 113 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 114 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 115 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 116 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 117 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 118 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 119 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 120 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 121 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 122 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 123 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 124 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 125 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 126 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 127 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 128 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 129 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 130 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 131 GERMANY: MACROECONOMIC INDICATORS
TABLE 132 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 133 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 134 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 135 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 136 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 137 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 138 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 139 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 140 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 141 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 142 UK: MACROECONOMIC INDICATORS
TABLE 143 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 144 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 145 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 146 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 147 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 148 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 149 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 151 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 152 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 153 FRANCE: MACROECONOMIC INDICATORS
TABLE 154 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 155 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 156 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 157 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 158 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 159 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 160 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 161 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 162 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 163 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 164 ITALY: MACROECONOMIC INDICATORS
TABLE 165 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 166 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 167 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 168 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 169 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 170 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 171 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 172 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 173 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 174 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 175 SPAIN: MACROECONOMIC INDICATORS
TABLE 176 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 177 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 178 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 179 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 180 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 181 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 182 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 183 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 184 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 185 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 186 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 187 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 188 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 189 REST OF EUROPE: : GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 190 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 191 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 192 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 193 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 194 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
TABLE 195 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 196 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 198 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 199 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 200 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 201 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 202 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 203 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 204 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 205 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 206 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 207 JAPAN: MACROECONOMIC INDICATORS
TABLE 208 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 209 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 210 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 211 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 212 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 213 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 214 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 215 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 216 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 217 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 218 CHINA: MACROECONOMIC INDICATORS
TABLE 219 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 220 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 221 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 222 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 223 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 224 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 225 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 227 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 228 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 229 INDIA: MACROECONOMIC INDICATORS
TABLE 230 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 231 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 232 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 233 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 234 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 235 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 236 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 237 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 238 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 239 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 240 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 241 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 242 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 243 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 244 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 245 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 246 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 247 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 248 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 249 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 250 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 251 SOUTH KOREA: MACROECONOMIC INDICATORS
TABLE 252 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 253 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 254 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 255 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 256 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 257 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 258 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 259 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 260 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
TABLE 261 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 262 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 263 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 264 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 265 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 266 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 267 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 268 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 269 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 270 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET OVERVIEW
4.2 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE AND REGION (2023)
4.3 GEOGRAPHIC SNAPSHOT OF GASTROENTEROLOGY/GASTROINTESTINAL
PRODUCTS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of GI disorders
5.2.1.2 Technological advancements in gastroenterology products
5.2.1.3 Growing aging population
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory policies for GI products
5.2.2.2 Increasing healthcare costs
5.2.2.3 Unfavorable healthcare reforms in US
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing preference for minimally invasive surgery
5.2.4 CHALLENGES
5.2.4.1 Changing regulatory landscape
5.2.4.2 Shortage of trained physicians and endoscopists
5.3 INDUSTRY TRENDS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 Capsule endoscopy
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Laboratory testing
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Robotic surgery systems
5.5 VALUE CHAIN ANALYSIS
5.6 PORTER’S FIVE FORCE ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY ANALYSIS
5.7.1.1 North America
5.7.1.1.1 US
5.7.1.1.2 Canada
5.7.1.2 Europe
5.7.1.3 Asia Pacific
5.7.1.3.1 Japan
5.7.1.3.2 China
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 HS CODES: GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS
5.9.2 IMPORT DATA
5.9.3 EXPORT DATA
5.10 PRICING ANALYSIS
5.11 REIMBURSEMENT ANALYSIS
5.12 KEY CONFERENCES & EVENTS, 2024–2025
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 UNMET NEEDS ANALYSIS
5.15 END-USER EXPECTATIONS
5.16 ECOSYSTEM ANALYSIS
5.17 CASE STUDY ANALYSIS
5.18 SUPPLY CHAIN ANALYSIS
5.19 INVESTMENT & FUNDING SCENARIO
5.20 IMPACT OF GEN AI/AI ON GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
6 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE
6.1 INTRODUCTION
6.2 ENDOSCOPY DEVICES
6.2.1 FLEXIBLE ENDOSCOPES
6.2.1.1 Advantages such as flexibility and ease of use to drive demand for flexible endoscopes
6.2.2 RIGID ENDOSCOPES
6.2.2.1 Ability of rigid endoscopes to provide vertical-axis images of internal organs to support market growth
6.2.3 CAPSULE ENDOSCOPES
6.2.3.1 Non-invasive nature of capsule endoscopes to drive adoption
6.2.4 OTHER ENDOSCOPY DEVICES
6.3 ABLATION DEVICES
6.3.1 RADIOFREQUENCY ABLATION DEVICES
6.3.1.1 Low cost of radiofrequency ablation to contribute to market growth
6.3.2 MICROWAVE ABLATION DEVICES
6.3.2.1 Advantages over RF ablation to ensure sustained demand for microwave ablation devices
6.3.3 CRYOABLATION DEVICES
6.3.3.1 Increasing cancer incidence to drive market for cryoablation devices
6.3.4 LASER ABLATION DEVICES
6.3.4.1 High efficacy and safety to drive adoption of laser/light ablation devices
6.3.5 OTHER ABLATION DEVICES
6.4 MOTILITY TESTING DEVICES
6.4.1 ESOPHAGEAL MANOMETRY DEVICES
6.4.1.1 Rising incidence of esophageal motility disorders to boost market growth
6.4.2 4-HOUR PH IMPEDANCE TESTING DEVICES
6.4.2.1 Ability to provide data useful for tailoring individualized treatment plans to favor market growth
6.4.3 ANORECTAL MANOMETRY DEVICES
6.4.3.1 Growing popularity of anorectal manometry devices for diagnosis of gastrointestinal problems to support market growth
6.4.4 OTHER MOTILITY TESTING DEVICES
6.5 BIOPSY DEVICES
6.5.1 NEEDLE BIOPSY DEVICES
6.5.1.1 Increasing screening of gastrointestinal diseases to aid growth
6.5.2 OTHER BIOPSY DEVICES
6.6 STENTING DEVICES
6.6.1 BILIARY STENTS
6.6.1.1 Increasing prevalence of bile duct cancer and chronic liver disease to drive growth
6.6.2 COLONIC STENTS
6.6.2.1 Rising demand for colonic stents due to high incidence of colorectal cancer to drive segmental growth
6.6.3 DUODENAL STENTS
6.6.3.1 Increasing prevalence of intestinal malignancy to boost adoption of duodenal stents
6.6.4 PANCREATIC STENTS
6.6.4.1 Rising number of ERCP and PTC procedures to drive market growth
6.6.5 ESOPHAGEAL STENTS
6.6.5.1 Increasing incidence of esophageal cancer to propel market growth
6.7 PH MONITORING DEVICES
6.7.1 ESOPHAGEAL PH MONITORING CATHETERS
6.7.1.1 Growing sedentary lifestyles to drive demand
6.7.2 WIRELESS PH MONITORING CAPSULES
6.7.2.1 Reduced risk of open surgeries to boost market
6.7.3 AMBULATORY PH MONITORING SYSTEMS
6.7.3.1 Convenience and accuracy of ambulatory pH monitoring to drive market
6.8 OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES
6.8.1 GASTRIC BALLOONS
6.8.1.1 Minimally invasive nature of gastric balloons to boost adoption
6.8.2 GASTROINTESTINAL TUBES
6.8.2.1 Rising incidence of diseases to drive need for gastrointestinal tubes
6.8.3 HEMORRHOID TREATMENT DEVICES
6.8.3.1 Rising cases of hemorrhoids to support market growth
7 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE
7.1 INTRODUCTION
7.2 GASTROINTESTINAL CANCERS
7.2.1 CHANGING DIETS AND GROWING PREVALENCE OF OBESITY TO BOOST MARKET GROWTH
7.3 GASTROESOPHAGEAL REFLUX DISEASE
7.3.1 GROWING INCIDENCE OF GERD TO DRIVE MARKET GROWTH
7.4 IRRITABLE BOWEL SYNDROME (IBS)
7.4.1 GROWING IBS DISEASE BURDEN TO DRIVE DEMAND FOR GASTROINTESTINAL PRODUCTS
7.5 INFLAMMATORY BOWEL DISEASE (IBD)
7.5.1 GROWING USE OF CAPSULE ENDOSCOPES IN TREATING IBD TO FAVOR MARKET GROWTH
7.6 OTHER DISEASES
8 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.2.1 HIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL PROCEDURES IN HOSPITALS
8.3 AMBULATORY SURGICAL CENTERS & INDEPENDENT SURGICAL CENTERS
8.3.1 LOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE MARKET GROWTH
8.4 CLINICS
8.4.1 GROWING NEED FOR CLINICAL SCREENING TO DIAGNOSE GASTROINTESTINAL DISEASES TO BOOST MARKET
8.5 OTHER END USERS
9 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 US to dominate North American market during forecast period
9.2.3 CANADA
9.2.3.1 Increased availability of funding and presence of research institutes to propel market
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Favorable reimbursement scenario and increased geriatric population to aid market growth
9.3.3 UK
9.3.3.1 Rising investments by hospitals in new and advanced gastroenterology/gastrointestinal products to augment market growth
9.3.4 FRANCE
9.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth
9.3.5 ITALY
9.3.5.1 High per capita income and improved healthcare system to drive market
9.3.6 SPAIN
9.3.6.1 Growing prevalence of cardiovascular diseases to boost market growth
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 JAPAN
9.4.2.1 Favorable medical device reimbursement policies and public health insurance schemes to aid market growth
9.4.3 CHINA
9.4.3.1 Increasing geriatric population and increase in domestic manufacturers for gastrointestinal products to support growth
9.4.4 INDIA
9.4.4.1 Increasing incidence of diseases like diabetes to enhance market growth
9.4.5 AUSTRALIA
9.4.5.1 High incidence of cancer to propel market growth
9.4.6 SOUTH KOREA
9.4.6.1 Rapidly aging population and high incidence of gastrointestinal diseases to aid market growth
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Increase in private healthcare investments and rise in medical tourism to aid market growth
9.5.3 MEXICO
9.5.3.1 Increased government investment in healthcare infrastructure and technological advancements to aid market growth
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2 GCC COUNTRIES
9.6.2.1 Increasing investment in healthcare infrastructure and growing medical tourism to propel market growth
9.6.3 REST OF MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
10.3 REVENUE ANALYSIS, 2021–2023
10.4 MARKET SHARE ANALYSIS, 2023
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
10.5.5.1 Company footprint
10.5.5.2 Disease footprint
10.5.5.3 End-user footprint
10.5.5.4 Region footprint
10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
10.7.3 EXPANSIONS
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPANY VALUATION & FINANCIAL METRICS
10.9.1 FINANCIAL METRICS
10.9.2 COMPANY VALUATION
11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 OLYMPUS CORPORATION
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Product launches & approvals
11.1.1.3.2 Deals
11.1.1.3.3 Expansions
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 BOSTON SCIENTIFIC CORPORATION
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Product launches & approvals
11.1.2.3.2 Deals
11.1.2.4 MnM view
11.1.2.4.1 Right to win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 MEDTRONIC PLC
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Product approvals
11.1.3.3.2 Deals
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 STRYKER CORPORATION
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.4.3.1 Product approvals
11.1.4.3.2 Deals
11.1.4.3.3 Expansions
11.1.4.4 MnM view
11.1.4.4.1 Right to win
11.1.4.4.2 Strategic choices
11.1.4.4.3 Weaknesses & competitive threats
11.1.5 COOK MEDICAL
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.3.1 Product launches & approvals
11.1.5.3.2 Deals
11.1.5.4 MnM view
11.1.5.4.1 Right to win
11.1.5.4.2 Strategic choices
11.1.5.4.3 Weaknesses & competitive threats
11.1.6 FUJIFILM CORPORATION
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.6.3.1 Product launches & approvals
11.1.6.3.2 Other developments
11.1.7 CONMED CORPORATION
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.8 ETHICON (A JOHNSON & JOHNSON SUBSIDIARY)
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.8.3 Recent developments
11.1.8.3.1 Product launches & approvals
11.1.9 MERIT MEDICAL SYSTEMS
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.9.3 Recent developments
11.1.9.3.1 Product launches
11.1.10 STERIS PLC
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.11 KARL STORZ SE & CO. KG
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.11.3 Recent developments
11.1.11.3.1 Deals
11.2 OTHER PLAYERS
11.2.1 SHAILI ENDOSCOPY
11.2.2 TAEWOONG MEDICAL CO., LTD.
11.2.3 HOBBS MEDICAL, INC.
11.2.4 PENTAX MEDICAL
11.2.5 ERBE ELEKTROMEDIZIN
11.2.6 AMBU A/S
11.2.7 CAPSOVISION, INC.
11.2.8 INTROMEDIC, INC.
11.2.9 VIMEX ENDOSCOPY
11.2.10 TRIVITRON HEALTHCARE
11.2.11 MEDI-GLOBE CORPORATION
11.2.12 SONOSCAPE MEDICAL CORP.
11.2.13 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.
11.2.14 MEDSPIRA
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 GLOBAL HEALTHCARE EXPENDITURES, BY REGION, 2022–2023
TABLE 3 ASIA PACIFIC: HEALTHCARE EXPENDITURE, BY COUNTRY, 2022–2023
TABLE 4 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
PORTER’S FIVE FORCES ANALYSIS
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
TABLE 10 HS CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS
TABLE 11 IMPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 12 EXPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 13 AVERAGE SELLING PRICE OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS, BY KEY PLAYER, 2023 (USD)
TABLE 14 AVERAGE SELLING PRICE OF GASTROINTESTINAL PRODUCTS, BY REGION,
2021–2023
TABLE 15 REIMBURSEMENT CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL PROCEDURES
TABLE 16 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET:
KEY CONFERENCES & EVENTS, 2024–2025
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
TABLE 18 KEY BUYING CRITERIA FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
TABLE 19 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: UNMET NEEDS
TABLE 20 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: END-USER EXPECTATIONS
TABLE 21 CASE STUDY 1: AI-ENHANCED CAPSULE ENDOSCOPY FOR SMALL BOWEL
DISEASE DETECTION
TABLE 22 CASE STUDY 2: RADIOFREQUENCY ABLATION FOR BARRETT'S ESOPHAGUS
TABLE 23 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: AI INTEGRATION
TABLE 24 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 25 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 26 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (THOUSAND UNITS)
TABLE 27 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 28 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 29 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CAPSULE ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ENDOSCOPY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 33 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, VOLUME DATA 2022–2029 (THOUSAND UNITS)
TABLE 34 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 36 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MICROWAVE ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 37 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CRYOABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR LASER ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 41 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL MANOMETRY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 43 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR 4-HOUR PH IMPEDANCE TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 44 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ANORECTAL MANOMETRY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER MOTILITY TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 47 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR NEEDLE BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR OTHER BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 50 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 51 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (THOUSAND UNITS)
TABLE 52 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 BILIARY STENTS OFFERED BY PROMINENT PLAYERS
TABLE 54 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BILIARY STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 COLONIC STENTS OFFERED BY PROMINENT PLAYERS
TABLE 56 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR COLONIC STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 DUODENAL STENTS OFFERED BY PROMINENT PLAYERS
TABLE 58 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR DUODENAL STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 59 PANCREATIC STENTS OFFERED BY PROMINENT PLAYERS
TABLE 60 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PANCREATIC STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 ESOPHAGEAL STENTS OFFERED BY PROMINENT PLAYERS
TABLE 62 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 64 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 65 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL PH MONITORING CATHETERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 66 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR WIRELESS PH MONITORING CAPSULES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY PH MONITORING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 69 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 70 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTRIC BALLOONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL TUBES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 72 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HEMORRHOID TREATMENT DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 73 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 74 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL CANCERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD), BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 76 TYPES OF IBS WITH SEVERITY INDEX
TABLE 77 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR IRRITABLE BOWEL SYNDROME (IBS), BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR INFLAMMATORY BOWEL DISEASE (IBD), BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 80 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 81 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 82 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY SURGICAL CENTERS & INDEPENDENT DIAGNOSTIC CENTERS, BY COUNTRY,
2022–2029 (USD MILLION)
TABLE 83 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CLINICS,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 86 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 87 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 89 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 90 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 92 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 93 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 94 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
TABLE 96 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 97 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2024
TABLE 98 LIST OF DEVICES THAT RECEIVED FDA APPROVALS BETWEEN 2020 AND 2023
TABLE 99 US: MACROECONOMIC INDICATORS
TABLE 100 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 101 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 102 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 103 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 104 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 105 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 106 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 107 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 108 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 109 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 110 CANADA: MACROECONOMIC INDICATORS
TABLE 111 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 112 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 113 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 114 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 115 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 116 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 117 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 118 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 119 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 120 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 121 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 122 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 123 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 124 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 125 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 126 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 127 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 128 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 129 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 130 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 131 GERMANY: MACROECONOMIC INDICATORS
TABLE 132 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 133 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 134 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 135 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 136 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 137 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 138 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 139 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 140 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 141 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 142 UK: MACROECONOMIC INDICATORS
TABLE 143 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 144 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 145 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 146 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 147 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 148 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 149 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 150 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 151 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 152 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 153 FRANCE: MACROECONOMIC INDICATORS
TABLE 154 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 155 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 156 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 157 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 158 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 159 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 160 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 161 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 162 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 163 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 164 ITALY: MACROECONOMIC INDICATORS
TABLE 165 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 166 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 167 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 168 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 169 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 170 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 171 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 172 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 173 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 174 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 175 SPAIN: MACROECONOMIC INDICATORS
TABLE 176 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 177 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 178 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 179 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 180 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 181 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 182 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 183 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 184 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 185 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 186 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 187 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 188 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 189 REST OF EUROPE: : GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 190 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 191 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 192 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 193 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 194 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
TABLE 195 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 196 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 198 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 199 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 200 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 201 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 202 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 203 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 204 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 205 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 206 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 207 JAPAN: MACROECONOMIC INDICATORS
TABLE 208 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 209 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 210 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 211 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 212 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 213 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 214 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 215 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 216 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 217 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 218 CHINA: MACROECONOMIC INDICATORS
TABLE 219 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 220 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 221 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 222 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 223 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 224 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 225 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 227 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 228 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 229 INDIA: MACROECONOMIC INDICATORS
TABLE 230 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 231 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 232 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 233 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 234 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 235 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 236 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 237 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR
OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 238 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 239 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 240 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 241 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DEVICE, 2022–2029 (USD MILLION)
TABLE 242 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 243 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 244 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 245 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 246 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 247 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 248 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 249 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY DISEASE, 2022–2029 (USD MILLION)
TABLE 250 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 251 SOUTH KOREA: MACROECONOMIC INDICATORS
TABLE 252 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 253 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 254 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 255 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 256 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 257 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 258 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 259 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE,
2022–2029 (USD MILLION)
TABLE 260 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
TABLE 261 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 262 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
TABLE 263 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 264 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 265 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 266 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 267 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 268 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 269 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 270 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
